Deal, C, Brown, JP, Recker, R
, Prince, R, Kiel, DP, Alvaro-Gracia, JM, De Gregorio, LH, Hadji, P, Hofbauer, LC, Wang, H, Austin, M, Newmark, R, Libanati, C, Wagman, RB, Martin, JS & Bone, HG 2008,
Direct comparison of changes in bone density and bone turnover markers in postmenopausal women with low bone mass treated with 6-monthly denosumab or weekly alendronate (Fosamax (R). in
ARTHRITIS AND RHEUMATISM. vol. 58, pp. S940-S940, Direct comparison of changes in bone density and bone turnover markers in postmenopausal women with low bone mass treated with 6-monthly denosumab or weekly alendronate (Fosamax (R).,
1/01/08.